1Y Close · As of Aug 26, 2026
REYON PHARMACEUTICAL operates in the Pharmaceuticals sector.
Legal name: REYON PHARMACEUTICAL CO., LTD
In fiscal year 2025, REYON PHARMACEUTICAL (102460) reported revenue of 145.9 billion KRW, down 1.6% from 148.3 billion KRW a year earlier.
Operating profit was -30.3 billion KRW and net income was -29.6 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 187.5 billion KRW, with a P/B of 0.85.
These figures can be verified in the DART filing (receipt no. 20260320001314).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 145.9B | -30.3B | -29.6B |
| 2024 | 148.3B | 79M | 4.2B |
| 2023 | 151.1B | 4.0B | 3.6B |
| 2022 | 154.0B | 9.6B | 7.4B |
| 2021 | 142.8B | 3.7B | 5.5B |
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |